Increasing awareness of effective pain management options is expected to drive opioid market growth over the forecast period.
New York, USA, Dec. 19, 2024 (GLOBE NEWSWIRE) — Market Overview
The global opioid market is projected to grow from USD 23.70 billion in 2024 to USD 28.45 billion by 2034 at a CAGR of 1.8%, as per a recent report by Polaris Market Research.
Market Introduction
What are Opioids?
A class of drugs known as opioids is used to treat moderate to severe pain. Opioids can be produced from the plant of opium poppy or in a laboratory. By attaching themselves to opioid receptors on nerve cells in the nervous system or other body organs, they block pain signals. Opioids affect the brain in many ways, including reducing pain. Both illegal and prescription painkillers contain opioids. Because opioids can cause euphoria or a “high,” some people use them by illegal means. Opioid use disorder (OUD), another name for addiction, can be brought on by opioid drugs.
Download Free Sample PDF Copy of Report:
Opioid Market Report and Scope Attributes
| Report Attribute | Details |
| Market Value in 2025 | USD 23.70 billion |
| Market value by 2034 | USD 28.45 billion |
| CAGR | 1.8% from 2025 to 2034 |
| Base Year | 2024 |
| Historical Data | 2020–2023 |
| Forecast Period | 2025–2034 |
Leaders in Opioid Market
Significant market developments include contractual agreements, mergers and acquisitions, new product launches, increased investment, and collaboration with other organizations. Among the top companies in the market are:
- Pfizer Inc.
- Rhodes Pharmaceuticals L.P.
- Sun Pharmaceutical Industries Limited
- Trevena Inc.
- Teva Pharmaceutical Industries Ltd.
- Actavis Plc.
- Amneal Pharmaceuticals LLC
- Boehringer Ingelheim International GmbH
- Cadila Healthcare Limited
- Fresenius Kabi
- Endo International plc
- Johnson & Johnson Corporation
- Lupin Limited
- Aurobindo Pharma Limited
- Assertio Therapeutics, Inc.
Request for Discount on this Report Before Purchase:
Market Growth Drivers and Opportunities
Growing Incidence of Traumatic Injuries
Traumatic injuries frequently cause acute and chronic pain, necessitating effective pain management strategies. Opioids are commonly prescribed in these cases to effectively manage pain because they provide significant relief, which is essential for recovery and rehabilitation. Furthermore, growing awareness of the long-term effects of TBIs has increased the demand for comprehensive pain management strategies, including opioid prescriptions. As a result, the increasing prevalence of traumatic injuries is significantly driving the opioid market growth.
Growing Investments in the Development of Medical Infrastructure
Government investments in healthcare to improve infrastructure and reduce disparities between urban and rural healthcare settings are expected to drive opioid market expansion over the forecast period. Increased healthcare spending worldwide, combined with a focus on improving healthcare access in underserved areas, is expected to drive up opioid prescriptions. The expansion of healthcare facilities will increase patient care services, driving up demand for pain management solutions, including opioids.
Regional Overview
North America had the largest revenue share in the opioid market in 2024, owing to advanced healthcare infrastructure that encourages higher pain management prescription rates. Additionally, as hospitals expand services and improve care delivery, demand for opioids as an effective pain relief option is expected to rise, boosting opioid market demand during the forecast period.
Asia Pacific is expected to have the highest CAGR during the forecast period, owing to its high population density and growing healthcare demand. With growing populations, particularly in aging societies like Japan and China, the demand for effective pain management solutions is increasing. Furthermore, the growing number of mergers and acquisitions and strategic partnerships between global and local players is increasing market accessibility and fostering innovation.
Inquire more about this report before purchase:
Opioid Market Segmentation
By Class Outlook (Revenue – USD Billion, 2020–2034)
- Natural
- Semi-Synthetic
- Fully Synthetic
By Product Outlook (Revenue – USD Billion, 2020–2034)
- Codeine
- Fentanyl
- Oxycodone
- Methadone
- Morphine
- Hydrocodone
- Tramadol
- Propoxyphene
- Others
By Release Type Outlook (Revenue – USD Billion, 2020–2034)
- Immediate-Release/Short-Acting Opioid
- Extended-Release/Long-Acting Opioid
By Application Outlook (Revenue – USD Billion, 2020–2034)
- Pain Management
- Neuropathic
- Migraine
- Orthopedic and Musculoskeletal
- Arthritis
- Fibromyalgia
- Others
- Cancer Pain
- Brain
- Breast
- Colorectal
- Blood
- Skin
- Prostate
- Others
- Cough Treatment
- Analgesia
- Diarrhea Treatment
- De-addiction
- Others
By Regional Outlook (Revenue – USD Billion, 2020–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
More Trending Latest Reports by Polaris Market Research:
Targeted DNA RNA Sequencing Market Analysis
Medical Automation Market Share
Ultrasound Transducer Market Size
Drug Device Combination Products Market Trends
Breast Cancer Liquid Biopsy Market Share
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
- RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives - June 13, 2025
- ITM to Provide COMPETE Trial Insights at SNMMI 2025 Annual Meeting in Oral Presentation and Satellite Symposium - June 13, 2025
- UCLOUDLINK GROUP INC. to Refrain From Capital Raising Activities under Form F-3 Registration Statement to Focus on Long-Term Value Creation - June 13, 2025
